ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.22
0.03%
US Tech 100
19,287.60
-0.24%
S&P 500
5,702.55
-0.19%
US Dollar vs CAD
1.35775
0.00%
Bitcoin
62,969.00
-0.64%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Juno Therapeutics, Inc. (delisted) (JUNO) Share Price

Juno Therapeutics, Inc. (delisted)

Juno Therapeutics, Inc. (delisted) (JUNO)

NASDAQ
86.96
0.00
(0.00%)
Closed September 22 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
86.96
Bid
77.15
Ask
87.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
86.96
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

JUNO Latest News

More News

Celgene Receives Antitrust Clearance for Juno Acquisition

Celgene Corporation (NASDAQ:CELG) today announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with respect to the previously...

February 21 2018
Business Wire

WeissLaw LLP Investigates Juno Therapeutics Inc. Acquisition

WeissLaw LLP Investigates Juno Therapeutics Inc. Acquisition PR Newswire NEW YORK, Jan. 24, 2018 NEW YORK, Jan. 24, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of...

January 24 2018
PR Newswire (US)

Drug Firms Bet Billions on Biotech -- WSJ

By Jonathan D. Rockoff This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (January 23...

January 23 2018
Dow Jones News

Big Drugmakers Pay Big Prices for Promising Biotechs -- Update

By Jonathan D. Rockoff Big drugmakers, searching for new sources of revenue, are paying hefty premiums for biotechnology businesses, with two multibillion-dollar acquisitions announced Monday...

January 22 2018
Dow Jones News

Big Drugmakers Pay Big Prices for Promising Biotechs

By Jonathan D. Rockoff A pair of multibillion-dollar biotech deals announced Monday commanded hefty premiums, driven by big drugmakers' need for new sources of revenue amid a scarcity of...

January 22 2018
Dow Jones News

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Juno Therapeutics, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Juno Therapeutics, Inc. PR Newswire NEW YORK, Jan. 22, 2018 NEW YORK, Jan. 22, 2018 /PRNewswire/ -- Rowley Law PLLC is...

January 22 2018
PR Newswire (US)

Celgene to Buy Juno Therapeutics for $9 Billion -- 2nd Update

By Cara Lombardo Celgene Corp. on Monday said it agreed to buy Juno Therapeutics Inc. for $87 a share in cash, or about $9 billion, in a move that will expand Celgene's portfolio of...

January 22 2018
Dow Jones News

Johnson Fistel, Announces Investigations of the Proposed Sales of Bioverativ Inc., and Juno Therapeutics, Inc.

Johnson Fistel, Announces Investigations of the Proposed Sales of Bioverativ Inc., and Juno Therapeutics, Inc. PR Newswire SAN DIEGO, Jan. 22, 2018 SAN DIEGO, Jan. 22, 2018 /PRNewswire/...

January 22 2018
PR Newswire (US)

Celgene to Buy Juno Therapeutics for $9 Billion -- Update

By Cara Lombardo Celgene Corp. on Monday said it agreed to buy Juno Therapeutics Inc. for $87 a share in cash, or about $9 billion, in a move that will expand Celgene's portfolio of...

January 22 2018
Dow Jones News

Celgene to Buy Juno Therapeutics For $9 Billion

By Cara Lombardo Celgene Corp. (CELG) on Monday said it agreed to buy Juno Therapeutics Inc. (JUNO) for $87 a share in cash, or about $9 billion, in a move that will bolster Celgene's...

January 22 2018
Dow Jones News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BNZIBanzai International Inc
US$ 5.645
(96.01%)
61.39M
ZJYLJin Medical International Ltd
US$ 3.975
(50.00%)
1.24M
ANEBAnebulo Pharmaceuticals Inc
US$ 2.9001
(39.43%)
78.85k
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
AENTAlliance Entertainment Holding Corporation
US$ 2.74
(34.31%)
4.23M
GSIWGarden Stage Ltd
US$ 1.34
(-82.89%)
26.44M
CRBPCorbus Pharmaceuticals Holdings Inc
US$ 19.51
(-62.26%)
12.29M
LGCBLinkage Global Inc
US$ 0.4183
(-57.70%)
2.16M
BFIBurgerFi International Inc
US$ 0.0855
(-42.27%)
15.05M
SKYESkye Bioscience Inc
US$ 3.17
(-42.26%)
5.14M
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
NVDANVIDIA Corporation
US$ 116.00
(-1.59%)
378.16M
AAPLApple Inc
US$ 228.20
(-0.29%)
320.24M
INTCIntel Corporation
US$ 21.84
(3.31%)
261.68M
VERBVerb Technology Company Inc
US$ 0.0742
(33.45%)
178.65M

Discussion

View Full Feed
misterfishman misterfishman 5 minutes ago
We all would be.
IGPK
stockprofitter stockprofitter 5 minutes ago
Kamala Harris is owned by BlackRock

BlackRock recently bought 21 million shares Fannie / Freddie common

End of message
FNMA
Investor082 Investor082 7 minutes ago
A partnership that does not bring in non dilutive cash is not valuable to NWBO at this stage. They have no money to run any trial themselves. Plus, a big pharma partnership with significant non dilutive cash injection validates potential of NWBO product both from commercial and technological perspec
NWBO
redspeed redspeed 12 minutes ago
Sorry I didn't respond to your public posts
itrade60 - Thursday, September 05, 2024 5:03:53 PM

No more free DD for you. You’ll have all your answers very soon when they unveil their plan. Tick tock tick tock moshi.
Free DD? I think Maria, War and myself are the only ones
MONI
rocketeer357 rocketeer357 28 minutes ago
Yup, some really ugly games in Milwaukee lately. Gotta hope they find some life within the next week because another opening round playoff loss would be very hard to accept for fans.
Steady_T Steady_T 34 minutes ago
Actually that is not true. Missling reduce the communications remarkedly after the first class action law suit. Seems like learning to me.
AVXL
Steady_T Steady_T 41 minutes ago
You do realize how lame that is in the context of what the company is doing and where it is headed, right?
AVXL
redspeed redspeed 47 minutes ago
How many times does a REAL company amend a filings?

https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=MOONEQUITYHOLDINGS%20P050000662694&aggregateId=domp-p05000066269-4fb2ff81-5d9d-45dc-a189-116ef26bb484
MONI
janice shell janice shell 52 minutes ago
EEEEEUUUWWWWW!!
Porch Honkey Porch Honkey 53 minutes ago
Them patents sure look nice, qTerm, our innovative health device, offers real-time monitoring of temperature, heartbeat, oxygen levels, and more.
Revolutionize your health management with ?????? ????????????????????????!
???????? ???????? ????????👇
https://gbtti.com
GTCH
redspeed redspeed 53 minutes ago
Intellectual property is always a concern. But future fresh ideas are like making past the pack at Rincon and the wave ahead is all yours Yoo-hoo !

If I was the company interviewed by Oprah and I got that word salad answer I'd sell all my shares

The company you PUMP h
MONI
Ron Burgandy79 Ron Burgandy79 53 minutes ago
I’m a shareholder and I expect more out of the people running the company. It’s as simple as that. They are taking advantage of us. Is that not clear to you?
DBMM
Ron Burgandy79 Ron Burgandy79 53 minutes ago
I’m a shareholder and I expect more out of the people running the company. It’s as simple as that. They are taking advantage of us. Is that not clear to you?
DBMM
k9narc k9narc 57 minutes ago
Sweet potato goes with compost.........

Pineapple goes with pizza.

It's a Canadian thing.
DR_rugby DR_rugby 1 hour ago
Let the games begin

https://m.youtube.com/watch?v=LXqCpqUHDY0

GLTA
GME

Your Recent History

NASDAQ
JUNO
JUNO THERAPEUTICS, INC.
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved